SourcingAI
Try for free
Powered by Made-in-China.com
Sensitive Antibiotics/Ampicillin and Sulbactam Sodium/GMP Factory
US$0.10
10,000-99,999 vial
US$1.00
100,000+ vial

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Internal Use

Model NO.

0.75g; 1.5g

Suitable for

Elderly, Children, Adult

State

Powder

Shape

Powder

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

H37021936

Transport Package

1vial/Box, 10vias/Box, 50vials/Box

Specification

50*38*36 CM

Trademark

Reyoung

Origin

China

Production Capacity

2, 000, 000, 000 Per Year

Key features

Broad Spectrum Indications: Treats respiratory, urinary tract infections, meningitis, salmonella, and endocarditis.
Multiple Administration Routes: Can be administered orally, intramuscularly, and intravenously.
GMP Certified Manufacturing: All workshops passed Chinese GMP and foreign audits including PIC/S.
Global Market Presence: Products sold to over 70 countries and NGOs worldwide since 1997.
OEM and ODM Services: Professional manufacturing with available OEM and ODM customization.
Established Manufacturer: Company established in 1966 with over 50 years of industry experience.
Large Production Capacity: Three factory sites covering 1 million square meters with 30+ workshops.
Comprehensive Product Range: Offers powders, injections, tablets, capsules, granules, and APIs.

Company profile

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer established in 1998, with a significant workforce of 4950 employees and a substantial registered capital. The company holds important certifications like ISO9001:2015, and its production includes a broad range of products such as injectables and antibiotics. Reyoung has been engaged in export since 2020, with exports accounting for 31% to 40% of their sales. They have a strong production capability, operating over ten production lines with an annual output exceeding $100 million. Despite limited information on financial credibility and innovation capability, their comprehensive certifications and extensive history suggest robustness in these areas.
Supplier typeReyoung Pharmaceutical Co., Ltd. is a limited company based in Shandong, China, operating as a combined business entity.
CertificationsThe supplier holds ISO9001:2015, ISO14001:2015, ISO45001:2016 certifications, and complies with cGMP, PIC/S, and ANVISA GMP standards.
Production capacityWith over 10 production lines and a wide range of pharmaceutical products, Reyoung demonstrates strong production capability.
Client casesThe supplier has conducted transactions with international clients like HEREDIA ARACENA RENY EVELIN and STERILE INDIA PRIVATE LIMITED.

Product Q&A

Q:What is the drug approval number?
A:
The drug registration and approval number is H37021936.
Q:What are the indications for Ampicillin?
A:
It treats respiratory tract infections, urinary tract infections, meningitis, salmonella infections, and endocarditis.
Q:Can this product be used for newborns?
A:
Yes, it can be used to prevent group B streptococcal infection in newborns.
Q:What are the available administration methods?
A:
It can be administered orally, intramuscularly, and intravenously.
Q:Does the manufacturer offer OEM or ODM services?
A:
Yes, both OEM and ODM services are available.

Send Inquiry

*To:Reyoung Pharmaceutical Co., Ltd.Reyoung Pharmaceutical Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like